Home › NDC Lookup › RxCUI directory › RxCUI 313499

Trimipramine 50 MG Oral Capsule — RxCUI 313499

RxNorm drug concept · Semantic clinical drug
RxCUI 313499 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI313499
Official nameTrimipramine 50 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astrimipramine 50 MG (as trimipramine maleate ) Oral Capsule
FDA products mapped7
Package NDCs mapped10
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Trimipramine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Trimipramine is an antidepressant used to relieve symptoms of depression. It tends to work best for what's called endogenous depression — depression that comes from within, rather...
  • It's totally normal not to feel a difference right away. Most antidepressants, including trimipramine, take anywhere from 10 days to 4 weeks before you notice a real improvement in...
  • How long does it take for trimipramine to start working?
  • The most common ones are drowsiness, dry mouth, blurred vision, constipation, and dizziness — especially when you first start or after a dose increase. These often improve as your...
📖 Read our full Trimipramine guide →

🕸️ Concept Web — How Trimipramine 50 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Trimipramine 50 MG Oral Capsule RxCUI 313499

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Trimipramine 10834
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Trimipramine Oral Capsule 374238
    • Trimipramine Oral Product 1158830
    • Trimipramine Pill 1158831
    • Oral Capsule 316965
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Trimipramine 50 MG 330525

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Trimipramine 50 MG SCDC · 330525
  • Trimipramine Oral Capsule SCDF · 374238
  • Trimipramine Oral Product SCDG · 1158830
  • Trimipramine Pill SCDG · 1158831

📦 FDA Products & Package NDCs

7 products · 10 package NDCs
10 package NDCs map to RxCUI 313499 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51991-0944-01 100 CAPSULE in 1 BOTTLE (51991-944-01) Trimipramine Breckenridge Pharmaceutical, Inc. 2017-04-05
51991-0944-33 30 CAPSULE in 1 BOTTLE (51991-944-33) Trimipramine Breckenridge Pharmaceutical, Inc. 2019-06-11
51991-0945-01 100 CAPSULE in 1 BOTTLE (51991-945-01) Trimipramine Breckenridge Pharmaceutical, Inc. 2017-04-05
51991-0945-33 30 CAPSULE in 1 BOTTLE (51991-945-33) Trimipramine Breckenridge Pharmaceutical, Inc. 2019-06-11
51991-0946-01 100 CAPSULE in 1 BOTTLE (51991-946-01) Trimipramine Breckenridge Pharmaceutical, Inc. 2017-04-05
51991-0946-33 30 CAPSULE in 1 BOTTLE (51991-946-33) Trimipramine Breckenridge Pharmaceutical, Inc. 2019-06-11
64850-0850-30 30 CAPSULE in 1 BOTTLE (64850-850-30) Trimipramine Maleate Elite Laboratories, Inc. 2018-08-31
64850-0851-30 30 CAPSULE in 1 BOTTLE (64850-851-30) Trimipramine Maleate Elite Laboratories, Inc. 2018-08-31
64850-0852-30 30 CAPSULE in 1 BOTTLE (64850-852-30) Trimipramine Maleate Elite Laboratories, Inc. 2018-08-31
72162-2062-03 30 CAPSULE in 1 BOTTLE (72162-2062-3) Trimipramine Maleate Bryant Ranch Prepack 2023-06-14
Observed labelers: Breckenridge Pharmaceutical, Inc. (6) · Elite Laboratories, Inc. (3) · Bryant Ranch Prepack (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.